Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 48,900Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 68BEIGENE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 9447106

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213217

Patent Use Code : U-2145

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-04-22

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11911386

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-3715

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-01-19

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11911386

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-3720

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-01-19

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11911386

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-3719

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-01-19

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11911386

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-3718

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-01-19

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11911386

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-3717

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-01-19

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11911386

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-3716

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-01-19

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11884674

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-1745

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF P...

Patent Expiration Date : 2037-08-15

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11884674

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-2145

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-15

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ZANUBRUTINIB

US Patent Number : 11884674

Drug Substance Claim :

Drug Product Claim :

Application Number : 213217

Patent Use Code : U-2537

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-15

blank